PCBL Chemical Q1 FY27 Share Price & Earnings Call Analysis

₹286.80-1.80% today
Market cap
₹11,295 Cr
P/E
42.68
ROE
5.56%
PEG
-1.99
Price to sales
1.33
Debt to equity
1.25
52W high / low
₹372 / ₹232
Sales growth (5Y)
25.22%
EBITDA margin
13.10%
Net profit margin
2.62%
Promoter holding
53.38%
Sales (last year)
₹8,549 Cr

Incorporated in 1960, Company is a part of RP‑Sanjiv Goenka Group and is in the business of production of Carbon Black, speciality chemical and generation of electricity for the purpose of captive consumptions and sale of surplus to outsiders.[1]

Guidance scorecard · Q1 FY27 call

What PCBL Chemical Ltd's management guided
and where it ranks in Chemicals & Petrochemicals

#48of 71 in
Chemicals & Petrochemicals

RevenueQ1 FY27 call

10–20%
  • PCBL expects significant growth in both volume and value over the next 1-2 years, driven by increasing Indian demand and expansion in the U.S. and Europe markets.
  • Strong growth in specialty carbon blacks, with new product launches enhancing the portfolio.
  • Despite short-term volume timing issues, full-year high single-digit volume growth is anticipated.
  • Aquapharm Chemicals aims for revenue and margin growth through launching commercial phosphonates products, expanding green chelates, and geographic penetration in Europe and Latin America.
  • Oil and gas segment is expected to be volatile short-term but stabilize later, supporting growth.
  • Domestic carbon black sales grew 15% YoY while international volumes are expected to scale up as export logistics normalize.

2 more points from PCBL Chemical Ltd's call on revenue

Create a free account to keep reading this call

Full Q1 FY27 analysis

MarginsQ1 FY27 call

Flat

See what PCBL Chemical Ltd said on margins — free account, 30 seconds.

Full Q1 FY27 analysis

CapexQ1 FY27 call

Planned
  • FY27 greenfield expansion capex will be limited, with major expenses expected next year (refer to Andhra facility licensing progress).
  • Around INR100 crores of strategic capex planned in FY27, mainly efficiency and cost optimization projects.
  • Overall FY27 capex outlook: ~INR300 crores, plus/minus INR50 crores, mostly maintenance and productivity enhancements; greenfield expansion largely completed.
  • Coal tar distillation project progressing well; business plan and equipment evaluation underway with capex approval targeted within the quarter.
  • Focus on volume and value growth in carbon black, specialty chemicals, and new product developments driving future investments.

2 more points from PCBL Chemical Ltd's call on capex

Create a free account to keep reading this call

Full Q1 FY27 analysis

FundraisingQ1 FY27 call

See what PCBL Chemical Ltd said on fundraising — free account, 30 seconds.

Full Q1 FY27 analysis

Order bookQ1 FY27 call

  • Some international customer orders were not fully delivered in Q1 due to high logistics costs impacting margins.
  • Management expects volumes to pick up significantly in Q3 and Q4, indicating a healthy future order flow.
  • Advanced stage negotiations with international customers, especially in U.S. and Europe, imply a strong pipeline.

2 more points from PCBL Chemical Ltd's call on the order book

Create a free account to keep reading this call

Full Q1 FY27 analysis

Ranges are what management guided for revenue growth and margins on the latest earnings call. Not investment advice, and not a forecast of returns.

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. 2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹263 Cr3.4
240%+Flat₹4,375 Cr83.7
340%+Flat₹3,259 Cr4.0
440%+Flat₹145 Cr15.9
520–40%Up 2%+₹1.81L Cr90.9
620–40%Up 2%+₹48,366 Cr78.3

Sign up free to see every company in the sector ranking and track PCBL Chemical Ltd.

Pro shows every company guiding 40%+ revenue growth →Full Chemicals & Petrochemicals ranking

Financials of PCBL Chemical Ltd

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Financials of PCBL Chemical Ltd

Quarterly Results

Quarter-by-quarter operating performance

Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Sales +1,3741,3481,4871,6571,9292,1442,1632,0102,0872,1142,1641,8462,066
Expenses +1,1901,1371,2491,3781,6191,7851,8001,6931,7901,7951,8971,6311,823
Operating Profit184211238279310358364317298319266215243
OPM %13%16%16%17%16%17%17%16%14%15%12%12%12%
Other Income +17437231161120612-50
Interest1919213210812111911810311210710697
Depreciation34414853758486878892939494
Profit before tax148154172201149164164124126120781052
Tax %31%29%28%26%26%28%25%25%21%22%21%80%23%
Net Profit +102109123148111118123931009462240
EPS in Rs2.712.893.253.922.953.133.272.472.652.491.630.051.02

Financials of PCBL Chemical Ltd

Profit & Loss

Annual income statement trend

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Sales +2,4701,8941,9272,5583,5293,2442,6604,4465,7746,4208,4048,189
Expenses +2,3191,7291,6622,1752,9122,7782,1433,7935,0435,3837,0677,146
Operating Profit1511652653836164655176537311,0371,3371,043
OPM %6%9%14%15%17%14%19%15%13%16%16%13%
Other Income +141612232028192841374714
Interest957251413746342953181461423
Depreciation586261616692110121137217346373
Profit before tax1247165304533355392532582676577261
Tax %14%66%58%24%28%19%20%20%24%27%25%24%
Net Profit +101669230383288314426442491435198
EPS in Rs0.310.462.016.6411.138.319.1011.2911.7013.0111.515.03
Dividend Payout %32%54%30%11%16%42%38%44%47%42%48%0%

Financials of PCBL Chemical Ltd

Balance Sheet

Capital structure and asset base

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity Capital343434343434343838383839
Reserves4731,0101,0961,3431,6151,6651,9012,5762,7923,2093,6603,967
Borrowings +1,2201,0227587177936177247861,0294,9835,5714,989
Other Liabilities +2855246917769449951,0671,3851,5733,0662,4532,299
Total Liabilities2,0122,5902,5802,8713,3873,3113,7264,7855,43311,29511,72211,295
Fixed Assets +8511,4161,3881,3991,5001,6401,7421,9341,9686,8926,5957,145
CWIP808080671753062671751,130433732566
Investments86228291316362155196588234433516464
Other Assets +9958678221,0901,3501,2101,5212,0872,1013,5373,8793,119
Total Assets2,0122,5902,5802,8713,3873,3113,7264,7855,43311,29511,72211,295

Financials of PCBL Chemical Ltd

Cash Flows

Operating, investing and financing cash movement

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +354223462932905323852905041,1057601,576
Cash from Investing Activity +-68-121-36-34-278-107-203-541-552-4,214-690-675
Cash from Financing Activity +34-262-337-110-70-389-180217-313,381-64-990
Net Cash Flow139-27148-58363-34-782726-89
Free Cash Flow238830619858301271-16-392573-4851
CFO/OP24%262%143%94%68%129%87%60%92%127%70%158%

Financials of PCBL Chemical Ltd

Ratios

Working capital efficiency and return ratios

Mar 2015Mar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days778488746866979170977862
Inventory Days5666726873541017048828065
Days Payable28741238881701341068014710092
Cash Conversion Cycle1057737546051645538325735
Working Capital Days-34-80-57-34-1-415174-11-24-40
ROCE %6%6%11%17%25%16%17%18%17%14%12%8%

Guidance history

How PCBL Chemical Ltd's guidance has moved, call by call

CallRevenueMarginsCapexFundraisingOrder book
Q1 FY27 call →10–20%FlatPlanned——
Q4 FY26 call →20–40%Up 2%+Planned——
Q3 FY26 call →10–20%FlatPlannedNone planned—
Q2 FY26 call →10–20%Up 2%+Planned——

What management guided on each call, newest first. Not investment advice, and not a forecast of returns.

20out of 100

Momentum score · price trend

20 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−22.9%33%
Last 6 months−1.3%52%
Last 3 months−12.6%34%

The price is 50% below its all-time high of ₹573.45 (27 Sept 2024). Stocks more than 20% below their peak have their score halved, so 41 became 20.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For PCBL Chemical Ltd: 0.4 × 33 + 0.4 × 52 + 0.2 × 34 = 41, halved to 20 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 29 Oct 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

Others in Chemicals & Petrochemicals this season

  • POCL Enterprises Ltd (Q1 FY27)

    466.03 crores (Page 12, 17, 11) . Key investor presentation takeaways from POCL Enterprises Ltd's Q1 FY27 investor presentation — and how it ranks against secto

  • Deepak Nitrite Ltd (Q2 FY27)

    Q2 FY27 total revenue: ₹3,091 crore, up 61% YoY (Page 1, 4, 5, 6, 10, 11) . Key investor presentation takeaways from Deepak Nitrite Ltd's Q2 FY27 investor prese

  • Privi Speciality Chemicals Ltd (Q2 FY27)

    19,239.47 lakhs (approximately 33.9% growth). Key results statement takeaways from Privi Speciality Chemicals Ltd's Q2 FY27 results statement — and how it ranks

  • NOCIL Ltd (Q2 FY27)

    427 crores . Key investor presentation takeaways from NOCIL Ltd's Q2 FY27 investor presentation — and how it ranks against sector peers.